High-throughput protein characterization using mass spectrometric immunoassay.
about
Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassayMicroheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variantsEfficient sample preparation in immuno-matrix-assisted laser desorption/ionization mass spectrometry using acoustic trapping.Detection of novel truncated forms of human serum amyloid A protein in human plasma.Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins.Metal ligand affinity pipettes and bioreactive alkaline phosphatase probes: tools for characterization of phosphorylated proteins and peptides.Alteration of transthyretin microheterogeneity in serum of multiple trauma patients.Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins within complex biofluids.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesInvestigating diversity in human plasma proteinsTargeted quantitative mass spectrometric immunoassay for human protein variants.MALDI-target integrated platform for affinity-captured protein digestionPopulation proteomics: addressing protein diversity in humans.Population proteomics: the concept, attributes, and potential for cancer biomarker research.Mass spectrometry-based immunoassays for the next phase of clinical applications.Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.Glycosylation status of vitamin D binding protein in cancer patients.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Biomarker rediscovery in diagnostics.Important options available--from start to finish--for translating proteomics results to clinical chemistry.Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications.Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Advantageous uses of mass spectrometry for the quantification of proteins.Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.
P2860
Q24794242-83264D4F-18B3-4014-A325-0AAAF2F59A08Q24811949-B5E9EE67-B51C-4EAD-B0D0-8758DAF4B92AQ28741516-1BD13353-7CBA-4CF1-BAC5-40D7C757CF30Q30441133-0F504209-7F56-4219-B7E9-E601B6AEF2A0Q31133257-20E11495-0D3F-4404-8B97-15D6162212D9Q33185913-15037FE9-2832-4109-8A96-DA1DBA33E6C3Q33196586-588DF1CF-2517-4582-B743-BF1030F9DBB4Q33491559-DA690CEC-EBD7-49D0-856D-46DE91C2C7E7Q33622969-ECA62024-7074-4D6E-926B-E84C9AA1ABE7Q33643266-19D8480D-7013-4EC4-B10F-948891DE7943Q33905685-F7B94103-F781-43C2-A64F-17550EFFAAA9Q34825391-988F8B61-4570-44E6-83AD-04CBBA345735Q35072160-CBBB6A74-647D-407D-A982-9CBE6A8B7B2BQ36184782-35AB77BC-9152-472D-9F16-7D79539E3519Q36492806-10760A3F-B97E-4790-9D2A-156DFDB07C57Q36689104-C44A6998-1E49-44B9-AA8B-E4847BF3CB05Q36841893-C494667E-B637-41BD-BB9A-8D7A0EC0DF4EQ37452925-F452D757-6615-497C-81A9-9B00BA5480BCQ37566426-62EF7350-D7D0-4587-92B3-7EEAFD8F9E94Q38089951-8699C438-90B8-4688-8C27-BA9E3E391311Q38282797-0D8B7BE8-2678-49ED-82BB-7739BD043DD7Q38649414-CDF88A1D-86EF-4B5C-8B08-D4B3D24551C0Q38816181-A0EE370D-A76D-4B15-9936-B4872E88023BQ41773275-3E2FE407-EEA5-4EAF-9589-9031C6B3E337Q42100819-C247CD9F-4CAB-4480-BAA8-9C8E620A17DA
P2860
High-throughput protein characterization using mass spectrometric immunoassay.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High-throughput protein characterization using mass spectrometric immunoassay.
@ast
High-throughput protein characterization using mass spectrometric immunoassay.
@en
type
label
High-throughput protein characterization using mass spectrometric immunoassay.
@ast
High-throughput protein characterization using mass spectrometric immunoassay.
@en
prefLabel
High-throughput protein characterization using mass spectrometric immunoassay.
@ast
High-throughput protein characterization using mass spectrometric immunoassay.
@en
P2093
P356
P1476
High-throughput protein characterization using mass spectrometric immunoassay.
@en
P2093
Dobrin Nedelkov
Eric E Niederkofler
Karl Gruber
Kemmons A Tubbs
Peter Williams
Randall W Nelson
Urban A Kiernan
P356
10.1006/ABIO.2001.5478
P407
P577
2002-02-01T00:00:00Z